title: Longer duration of continuous-flow ventricular assist device support predicts greater hemodynamic compromise after return of pulsatility.
authors.affiliation: College of Physicians and Surgeons, Columbia, University, New York, NY 10032, USA.
authors.forename: Allen S
authors.initials: AS
authors.lastname: Stewart
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Russo
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Martens
authors.forename: Tariq M
authors.initials: TM
authors.lastname: Naseem
authors.forename: Mario C
authors.initials: MC
authors.lastname: Deng
authors.forename: Ray
authors.initials: R
authors.lastname: Wang
authors.forename: Michael
authors.initials: M
authors.lastname: Argenziano
authors.forename: Mehmet
authors.initials: M
authors.lastname: Oz
authors.forename: Yoshifumi
authors.initials: Y
authors.lastname: Naka
mesh_terms: D002316:Cardiotonic Agents / Q000627:therapeutic use*; D016027:Heart Transplantation; D006353:Heart-Assist Devices; D006439:Hemodynamics; D006801:Humans; D008875:Middle Aged; D011673:Pulsatile Flow; D013997:Time Factors
chemical_list: D002316:Cardiotonic Agents